Home / World News / Moderna Covid-19 vaccine could be ready for use by end of year, says US

Moderna Covid-19 vaccine could be ready for use by end of year, says US

The trial is the first such late-stage study under the Trump administration's program to speed development of measures against the novel coronavirus

Premium

Moderna, which has never brought a vaccine to market, has received nearly $1 billion from the US government

3 min read Last Updated : Jul 28 2020 | 1:10 AM IST

Moderna Inc's vaccine against Covid-19 could be ready for widespread use by the end of this year, US and company officials said on Monday, after the drugmaker announced the start of a 30,000-subject trial to demonstrate it is safe and effective, the final hurdle prior to regulatory approval.

The trial is the first such late-stage study under the Trump administration's program to speed development of measures against the novel coronavirus, adding to hope that an effective vaccine will help end the pandemic. Moderna shares were up 7.5 per cent.

Moderna, which has never brought a vaccine to market, has received nearly $1

Topics : Coronavirus Coronavirus Vaccine Coronavirus Tests United States

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in